|
1
|
Shi KL, Qian JY, Qi L, Mao DB, Chen Y, Zhu
Y and Guo XG: Atorvastatin antagonizes the visfatin-induced
expression of inflammatory mediators via the upregulation of NF-κB
activation in HCAECs. Oncol Lett. 12:1438–1444. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kocełak P, Olszanecka-Glinianowicz M,
Owczarek AJ, Krupa W, Obirek P, Bożentowicz-Wikarek M, Brzozowska
A, Mossakowska M, Zdrojewski T, Skalska A, et al: Plasma
visfatin/nicotinamide phosphoribosyltransferase (visfatin/NAMPT)
concentration in elderly subjects with metabolic syndrome. Pol Arch
Med Wewn. 125:402–413. 2015.PubMed/NCBI
|
|
3
|
Owczarek AJ, Olszanecka-Glinianowicz M,
Kocełak P, Bożentowicz-Wikarek M, Brzozowska A, Mossakowska M,
Puzianowska-Kuźnicka M, Grodzicki T, Więcek A and Chudek J: The
relationship between circulating visfatin/nicotinamide
phosphoribosyltransferase, obesity, inflammation and lipids profile
in elderly population, determined by structural equation modeling.
Scand J Clin Lab Invest. 76:632–640. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ma Y, Cheng Y, Wang J, Cheng H, Zhou S and
Li X: The changes of visfatin in serum and its expression in fat
and placental tissue in pregnant women with gestational diabetes.
Diabetes Res Clin Pract. 90:60–65. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Porter B, Babbar S, Ye SQ and Maulik D:
The role of nicotinamide phosphoribosyltransferase in pregnancy: A
review. Am J Perinatol. 33:1327–1336. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun L, Chen S, Gao H, Ren L and Song G:
Visfatin induces the apoptosis of endothelial progenitor cells via
the induction of pro-inflammatory mediators through the NF-κB
pathway. Int J Mol Med. 40:637–646. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vejrazkova D, Lischkova O, Vankova M,
Stanicka S, Vrbikova J, Lukasova P, Vcelak J, Vacinova G and
Bendlova B: Distinct response of fat and gastrointestinal tissue to
glucose in gestational diabetes mellitus and polycystic ovary
syndrome. Physiol Res. 66:283–292. 2017.PubMed/NCBI
|
|
8
|
Liang Z, Wu Y, Xu J, Fang Q and Chen D:
Correlations of serum visfatin and metabolisms of glucose and lipid
in women with gestational diabetes mellitus. J Diabetes Investig.
7:247–252. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hosseinzadeh-Attar MJ, Golpaie A, Foroughi
M, Hosseinpanah F, Zahediasl S and Azizi F: The relationship
between visfatin and serum concentrations of c-reactive protein,
interleukin 6 in patients with metabolic syndrome. J Endocrinol
Invest. 39:917–922. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Moschen AR, Kaser A, Enrich B, Mosheimer
B, Theurl M, Niederegger H and Tilg H: Visfatin, an adipocytokine
with proinflammatory and immunomodulating properties. J Immunol.
178:1748–1758. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kendal CE and Bryant-Greenwood GD:
Pre-B-cell colony-enhancing factor (Pbef/Visfatin) gene expression
is modulated by NF-kappaB and AP-1 in human amniotic epithelial
cells. Placenta. 28:305–314. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mayi TH, Duhem C, Copin C, Bouhlel MA,
Rigamonti E, Pattou F, Staels B and Chinetti-Gbaguidi G: Visfatin
is induced by peroxisome proliferator-activated receptor gamma in
human macrophages. FEBS J. 277:3308–3320. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Stromsdorfer KL, Yamaguchi S, Yoon MJ,
Moseley AC, Franczyk MP, Kelly SC, Qi N, Imai S and Yoshino J:
NAMPT-mediated NAD(+) biosynthesis in adipocytes regulates adipose
tissue function and multi-organ insulin sensitivity in mice. Cell
Rep. 16:1851–1860. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim HS, Han SY, Sung HY, Park SH, Kang MK,
Han SJ and Kang YH: Blockade of visfatin induction by oleanolic
acid via disturbing Il-6-TRAF6-NF-κB signaling of adipocytes. Exp
Biol Med (Maywood). 239:284–292. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lv Q, Wang Y, Wang W, Wang L and Zhou X:
Effect of pioglitazone on visfatin expression in 3T3-L1 adipocytes
and SD rats. Endocr Res. 34:130–141. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mrizak I, Grissa O, Henault B, Fekih M,
Bouslema A, Boumaiza I, Zaouali M, Tabka Z and Khan NA: Placental
infiltration of inflammatory markers in gestational diabetic women.
Gen Physiol Biophys. 33:169–176. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang J, Chi H, Xiao H, Tian X, Wang Y,
Yun X and Xu Y: Interleukin 6 (IL-6) and tumor necrosis factor α
(TNF-α) single nucleotide polymorphisms (SNPs), inflammation and
metabolism in gestational diabetes mellitus in inner Mongolia. Med
Sci Monit. 23:4149–4157. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Telejko B, Kuzmicki M, Zonenberg A,
Szamatowicz J, Wawrusiewicz-Kurylonek N, Nikolajuk A, Kretowski A
and Gorska M: Visfatin in gestational diabetes: Serum level and
mRNA expression in fat and placental tissue. Diabetes Res Clin
Pract. 84:68–75. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kralisch S, Klein J, Lossner U, Bluher M,
Paschke R, Stumvoll M and Fasshauer M: Interlenkin-6 is a negative
regulator of visfatin gene expression in 3T3-L1 adipocyts. Am J
Physicol Endocrinol Metab. 289:E586–E590. 2005. View Article : Google Scholar
|
|
20
|
McGee KC, Harte AL, da Silva NF, Al-Daghri
N, Creely SJ, Kusminski CM, Tripathi G, Levick PL, Khanolkar M,
Evans M, et al: Visfatin is regulated by rosiglitazone in Type 2
diabetes mellitus and influenced by NFκB and JNK in human abdominal
subcutaneous adipocytes. PLoS One. 6:e202872011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ognjanovic S, Bao S, Yamamoto SY,
Garibay-Tupas J, Samal B and Bryant-Greenwood GD: Genomic
organization of the gene coding for human pre-B-cell colony
enhancing factor and expression in human fetal membranes. J Mol
Endocrinol. 26:107–117. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ahmadian M, Suh JM, Hah N, Liddle C,
Atkins AR, Downes M and Evans RM: PPARγ signaling and metabolism:
The good, the bad and the future. Nat Med. 19:557–566. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Charrier A, Wang L, Stephenson EJ, Ghanta
SV, Ko CW, Croniger CM, Bridges D and Buchner DA: Zinc finger
protein 407 overexpression upregulates PPAR target gene expression
and improves glucose homeostasis in mice. Am J Physiol Endocrinol
Metab. 311:E869–E880. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Holdsworth-Carson SJ, Lim R, Mitton A,
Whitehead C, Rice GE, Permezel M and Lappas M: Peroxisome
proliferator-activated receptors are altered in pathologies of the
human placenta: Gestational diabetes mellitus, intrauterine growth
restriction and preeclampsia. Placenta. 31:222–229. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Suwaki N, Masuyama H, Masumoto A, Takamoto
N and Hiramatsu Y: Expression and potential role of peroxisome
proliferator-activated receptor gamma in the placenta of diabetic
pregnancy. Placenta. 28:315–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Capobianco E, Jawerbaum A, Romanini MC,
White V, Pustovrh C, Higa R, Martinez N, Mugnaini MT, Soñez C and
Gonzalez E: 15-Deoxy-∆12,14-prostaglandin J2 and peroxisome
proliferator-activated receptor γ (PPARγ) levels in term placental
tissues from control and diabetic rats: Modulatory effects of a
PPARγ agonist on nitridergic and lipid placental metabolism. Reprod
Fertil Dev. 17:423–433. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Szklanna PB, Wynne K, Nolan M, Egan K,
Áinle FN and Maguire PB: Comparative proteomic analysis of
trophoblast cell models reveals their differential phenotypes,
potential uses and limitations. Proteomics. Mar 20–2017;(Epub ahead
of print).
|
|
28
|
Orendi K, Gauster M, Moser G, Meiri H and
Huppertz B: The choriocarcinoma cell line BeWo: Syncytial fusion
and expression of syncytium-specific proteins. Reproduction.
140:759–766. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schimittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Barak Y, Sadovsky Y and Shalom-Barak T:
PPAR signaling in placental development and function. PPAR Res.
2008:1420822008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Choi KC, Ryu OH, Lee KW, Kim HY, Seo JA,
Kim SG, Kim NH, Choi DS, Baik SH and Choi KM: Effect of PPAR-alpha
and -gamma agonist on the expression of visfatin, adiponectin, and
TNF-alpha in visceral fat of OLETF rats. Biochem Biophys Res
Commun. 336:747–753. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bermudez B, Dahl TB, Medina I, Groeneweg
M, Holm S, Montserrat-de la Paz S, Rousch M, Otten J, Herias V,
Varela LM, et al: Leukocyte overexpression of intracellular NAMPT
attenuates atherosclerosis by regulating PPARγ-dependent monocyte
differentiation and function. Arterioscler Thromb Vasc Biol.
37:1157–1167. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang SJ, Choi JM, Kim L, Park SE, Rhee EJ,
Lee WY, Oh KW, Park SW and Park CY: Nicotinamide improves glucose
metabolism and affects the hepatic NAD-sirtuin pathway in a rodent
model of obesity and type 2 diabetes. J Nutr Biochem. 25:66–72.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tsai PJ, Davis J, Thompson K and
Bryant-Greenwood G: Visfatin/Nampt and SIRT1: Roles in postterm
delivery in pregnancies associated with obesity. Reprod Sci.
22:1028–1036. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin QQ, Geng YW, Jiang ZW and Tian ZJ:
SIRT1 regulates lipopolysaccharide-induced CD40 expression in renal
medullary collecting duct cells by suppressing the TLR4-NF-κB
signaling pathway. Life Sci. 170:100–107. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li L, Sun Q, Li Y, Yang Y, Yang Y, Chang
T, Man M and Zheng L: Overexpression of sirt1 induced by
resveratrol and inhibitor of miR-204 suppresses activation and
proliferation of microglia. J Mol Neurosci. 56:858–867. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tian Y, Ma J, Wang W, Zhang L, Xu J, Wang
K and Li D: Resveratrol supplement inhibited the NF-κB inflammation
pathway through activating AMPKα-SIRT1 pathway in mice with fatty
liver. Mol Cell Biochem. 422:75–84. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chigurupati S, Dhanaraj SA and Balakumar
P: A step ahead of PPARγ full agonists to PPARγ partial agonists:
Therapeutic perspectives in the management of diabetic insulin
resistance. Eur J Pharmacol. 755:50–57. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mayi TH, Rigamonti E, Pattou F, Staels B
and Chinetti-Gbaguidi G: Liver X receptor (LXR) activation
negatively regulates visfatin expression in macrophages. Biochem
Biophys Res Commun. 404:458–462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kirwan AM, Lenighan YM, O'Reilly ME,
McGillicuddy FC and Roche HM: Nutritional modulation of metabolic
inflammation. Biochem Soc Trans. 45:979–985. 2017. View Article : Google Scholar : PubMed/NCBI
|
